Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
5.61
+0.61 (12.20%)
At close: Dec 20, 2024, 4:00 PM
5.54
-0.07 (-1.25%)
After-hours: Dec 20, 2024, 7:50 PM EST
Sage Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 99.63 | 70.99 | 162.7 | 294.23 | 1,661 | 126.71 | Upgrade
|
| Short-Term Investments | 469.53 | 682.19 | 1,110 | 1,448 | 438.47 | 881.69 | Upgrade
|
| Cash & Short-Term Investments | 569.15 | 753.18 | 1,272 | 1,742 | 2,100 | 1,008 | Upgrade
|
| Cash Growth | -35.03% | -40.81% | -26.96% | -17.02% | 108.21% | 9.28% | Upgrade
|
| Receivables | 18.07 | 84.41 | 15.16 | 19.61 | - | - | Upgrade
|
| Inventory | - | 1.5 | 1.7 | 1.4 | - | - | Upgrade
|
| Prepaid Expenses | 16.43 | 28.93 | 47.63 | 37.34 | 22.82 | 26.7 | Upgrade
|
| Restricted Cash | 1.33 | 1.33 | - | - | - | - | Upgrade
|
| Total Current Assets | 604.99 | 869.35 | 1,337 | 1,801 | 2,122 | 1,035 | Upgrade
|
| Property, Plant & Equipment | 12.27 | 6.38 | 13.43 | 19.13 | 31.82 | 42.9 | Upgrade
|
| Other Long-Term Assets | 5.18 | 6.55 | 6.04 | 5.52 | 5.06 | 6.16 | Upgrade
|
| Total Assets | 622.43 | 882.28 | 1,356 | 1,825 | 2,159 | 1,084 | Upgrade
|
| Accounts Payable | 7.13 | 10.32 | 18.95 | 10.45 | 3.69 | 15.27 | Upgrade
|
| Accrued Expenses | 53.05 | 56.68 | 72.67 | 67.28 | 54.85 | 86.62 | Upgrade
|
| Current Portion of Leases | 0.08 | 5.17 | 7.64 | 7.47 | 8.66 | 10.24 | Upgrade
|
| Other Current Liabilities | 0.15 | 10.59 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 60.41 | 82.75 | 99.26 | 85.19 | 67.2 | 112.13 | Upgrade
|
| Long-Term Leases | 10.19 | - | 4.49 | 10.96 | 19.44 | 26.85 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.1 | 0.1 | 0.27 | 0.52 | Upgrade
|
| Total Liabilities | 70.6 | 82.75 | 103.85 | 96.26 | 86.91 | 139.5 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 3,426 | 3,370 | 3,291 | 3,227 | 3,110 | 2,587 | Upgrade
|
| Retained Earnings | -2,875 | -2,570 | -2,028 | -1,495 | -1,037 | -1,644 | Upgrade
|
| Treasury Stock | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 | Upgrade
|
| Comprehensive Income & Other | 0.9 | -0.81 | -10.21 | -2.66 | 0.42 | 1.3 | Upgrade
|
| Total Common Equity | 551.84 | 799.53 | 1,253 | 1,729 | 2,072 | 944.66 | Upgrade
|
| Shareholders' Equity | 551.84 | 799.53 | 1,253 | 1,729 | 2,072 | 944.66 | Upgrade
|
| Total Liabilities & Equity | 622.43 | 882.28 | 1,356 | 1,825 | 2,159 | 1,084 | Upgrade
|
| Total Debt | 10.27 | 5.17 | 12.13 | 18.43 | 28.1 | 37.09 | Upgrade
|
| Net Cash (Debt) | 558.88 | 748.02 | 1,260 | 1,724 | 2,071 | 971.3 | Upgrade
|
| Net Cash Growth | -35.69% | -40.65% | -26.89% | -16.78% | 113.27% | 5.26% | Upgrade
|
| Net Cash Per Share | 9.25 | 12.50 | 21.25 | 29.38 | 39.08 | 19.11 | Upgrade
|
| Filing Date Shares Outstanding | 61.17 | 60.11 | 59.72 | 59.05 | 58.38 | 51.91 | Upgrade
|
| Total Common Shares Outstanding | 61.17 | 60.04 | 59.51 | 58.94 | 58.31 | 51.88 | Upgrade
|
| Working Capital | 544.58 | 786.6 | 1,238 | 1,715 | 2,055 | 922.97 | Upgrade
|
| Book Value Per Share | 9.02 | 13.32 | 21.05 | 29.34 | 35.54 | 18.21 | Upgrade
|
| Tangible Book Value | 551.84 | 799.53 | 1,253 | 1,729 | 2,072 | 944.66 | Upgrade
|
| Tangible Book Value Per Share | 9.02 | 13.32 | 21.05 | 29.34 | 35.54 | 18.21 | Upgrade
|
| Machinery | - | 3.9 | 3.49 | 2.6 | 4.62 | 4.66 | Upgrade
|
| Leasehold Improvements | - | 5.51 | 5.51 | 5.39 | 9.22 | 8.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.